NBIX
Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Real-World Head-to-Head Claims Analysis Demonstrating Greater Treatment Persistence with INGREZZA® (valbenazine) Capsules Compared to AUSTEDO XR
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release
Neurocrine Biosciences, Inc (NBIX) Sec Form 8K
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 8K
Neurocrine Biosciences, Inc (NBIX) Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 M&A Release
Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Presents First Expert Consensus Recommendations for Tardive Dyskinesia in Long-Term Care Settings
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Other Release
Neurocrine Biosciences, Inc (NBIX) Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Management Update
Neurocrine Biosciences, Inc (NBIX) Forum
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Forum
Neurocrine Biosciences, Inc (NBIX) Q4 2025 Earnings Call Transcript
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Q4 2025 Earnings Call dated Feb. 11, 2026 Corporate Participants: Todd Tushla — Vice President…
Neurocrine Biosciences, Inc (NBIX) Leerink Global Healthcare Conference.
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference
Neurocrine Biosciences, Inc (NBIX) TD Cowen 46th Annual Health Care Conference
Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 Corporate Conference
Neurocrine Biosciences, Inc (NBIX) Sec Form 10K
Neurocrine Biosciences, Inc (NASDAQ: NBIX) Sec Form 10K